Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.
2.

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.

Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.

Br J Dermatol. 2004 Jun;150(6):1167-73.

PMID:
15214905
4.

Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.

Cassano N, Miracapillo A, Coviello C, Loconsole F, Bellino M, Vena GA.

Clin Drug Investig. 2006;26(4):227-33.

PMID:
17163256
7.

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.

Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, Douglas WS, Lowson D, Mascaro JM, Murphy GM, Stymne B.

Dermatology. 2002;205(4):389-93.

PMID:
12444337
8.

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.

Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.

Br J Dermatol. 2006 Jun;154(6):1155-60.

PMID:
16704648
10.
11.

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.

Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.

Dermatology. 2008;217(2):107-13. doi: 10.1159/000130425.

PMID:
18463448
12.
14.

Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.

Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G.

Dermatology. 2006;213(4):319-26.

PMID:
17135738
15.

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.

Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.

Eur J Dermatol. 2010 Jul-Aug;20(4):465-71. doi: 10.1684/ejd.2010.0948.

PMID:
20413372
16.

Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.

Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.

Br J Dermatol. 2009 Jul;161(1):159-66. doi: 10.1111/j.1365-2133.2009.09116.x.

PMID:
19416259
18.

Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.

White S, Vender R, Thaçi D, Haverkamp C, Naeyaert JM, Foster R, Martinez Escribano JA, Cambazard F, Bibby A.

Am J Clin Dermatol. 2006;7(3):177-84.

PMID:
16734505
19.

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.

Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S.

J Dermatolog Treat. 2007;18(6):361-5.

PMID:
17934937
20.

Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.

Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):919-26. doi: 10.1111/j.1468-3083.2009.03221.x.

PMID:
19453810

Supplemental Content

Support Center